5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
India
Global EPA & DHA Market is segmented by Type (Eicosapentaenoic Acid and Docosahexaenoic Acid); Form ( Triglycerides and Ethyl Esters); Source (Fish Oil, Algae Oil, Krill Oil, and Concentrates); Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Others) ; and by Geography
Study Period:
2016 - 2026
Base Year:
2020
Fastest Growing Market:
Asia Pacific
Largest Market:
North America
CAGR:
8.26 %
The global EPA & DHA market is projected to grow at the CAGR of 8.26% during the forecast period (2020 - 2025).
The market studied is segmented by type, form, source, application, and geography. By type, the market studied is segmented into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). By form, the market studied is segmented into triglycerides and ethyl esters. Based on the source, the market studied is segmented into, fish oil, algae oil, krill oil, and concentrates. By application, the study covers infant formulae, dietary supplements, fortified food and beverages, pharmaceuticals, and other applications. Furthermore, the report takes into consideration the market for meal replacement in established and emerging economies of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
By Type | |
Eicosapentaenoic Acid (EPA) | |
Docosahexaenoic Acid (DHA |
By Form | |
Triglycerides | |
Ethyl Esters |
By Source | |
Fish Oil | |
Algae Oil | |
Krill Oil | |
Concentrates |
By Application | |
Infant Formulae | |
Dietary Supplements | |
Fortified Food and Beverages | |
Pharmaceuticals | |
Other Applications |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Report scope can be customized per your requirements. Click here.
The DHA segment is majorly driven by the rising demand and its incorporation in infant formulae and nutritional products targeting children's health, as it is an essential building block for the growth and maturation of an infant's brain and retina. It is mostly obtained from fish and algae oils. Additionally, it is extensively used in fortified foods and dietary supplements, where it is majorly used for treating Type 2 diabetes, coronary artery disease (CAD), dementia, and attention deficit-hyperactivity disorder (ADHD). The healthy aging-related benefits of DHA have also led to their successful utilization in geriatric nutrition products. Furthermore, an increasing number of product launches across the world is favoring the industry growth. For instance, Organic Technologies, in 2017, launched two new DHA omega-3 concentrates to its line of AlaskOmega fish oils and concentrates—a high DHA concentrate, and a medium strength DHA (non-tuna) tuna oil alternative.
To understand key trends, Download Sample Report
The North America EPA and DHA ingredients market is primarily driven by innovations, both, in products and technologies. The leading players are investing in technological advancements, in order to get develop improved omega ingredients for wider applications. In October 2016, DSM launched a new process technology, 3C technology. The technology aids the manufacturers of omega-3 to produce highly concentrated ingredients (up to 85%). It also facilitates the manufacturers to customize the combinations of EPA and DHA for their application in pharmaceutical and dietary supplements. The trend of consumption of supplements instead of functional food is predominant in the region. Consumers prefer high concentrated dietary supplements to meet their nutritional requirements of DHA/EPA. Thus, driving the ingredient sector’s growth in the region.
To understand geography trends, Download Sample Report.
The global EPA and DHA market was moderately concentrated by few players, such as BASF SE, Croda International PLC, and Koninklijke DSM NV in 2019. Many small companies started commercial production of EPA and DHA, only to be acquired by larger players as a competitive strategy for major companies are focussing on investment in research and development to compete in the emerging market. Moreover, during the last few years, various global companies have become active in the global EPA and DHA market with tactical acquisitions, mergers, and partnerships. For instance, in 2017, Veramaris (established 50:50 joint venture between DSM & Evonik) in order to produce omega-3 fatty acids (containing rich amounts of EPA and DHA) derived from natural marine algae for animal nutrition. The other major players in the market are forming partnerships with different end-user industries, such as food and beverage, dietary supplements, and others primarily due to the increasing demand for sustainably sourced Omega-3 fortified food products as well as dietary supplements.
1. INTRODUCTION
1.1 Study Deliverable and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
3.1 Market Overview
4. MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 Eicosapentaenoic Acid (EPA)
5.1.2 Docosahexaenoic Acid (DHA
5.2 By Form
5.2.1 Triglycerides
5.2.2 Ethyl Esters
5.3 By Source
5.3.1 Fish Oil
5.3.2 Algae Oil
5.3.3 Krill Oil
5.3.4 Concentrates
5.4 By Application
5.4.1 Infant Formulae
5.4.2 Dietary Supplements
5.4.3 Fortified Food and Beverages
5.4.4 Pharmaceuticals
5.4.5 Other Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.1.4 Rest of North America
5.5.2 Europe
5.5.2.1 Spain
5.5.2.2 United Kingdom
5.5.2.3 Germany
5.5.2.4 France
5.5.2.5 Italy
5.5.2.6 Rest of Europe
5.5.3 Asia Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Singapore
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 South America
5.5.4.1 Brazil
5.5.4.2 Argentina
5.5.4.3 Rest of South America
5.5.5 Middle East and Africa
5.5.5.1 South Africa
5.5.5.2 United Arab Emirates
5.5.5.3 Rest of Middle East and Africa
6. COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 Koninklijke DSM NV
6.4.2 The Archer Daniels Midland Company
6.4.3 Corbion NV
6.4.4 Novasep Holding SAS
6.4.5 Neptune Wellness Solutions
6.4.6 BASF SE
6.4.7 Clover Corporation Ltd
6.4.8 Croda International PLC
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability